These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 3861793)

  • 1. Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.
    Hnatowich DJ; Griffin TW; Kosciuczyk C; Rusckowski M; Childs RL; Mattis JA; Shealy D; Doherty PW
    J Nucl Med; 1985 Aug; 26(8):849-58. PubMed ID: 3861793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody guided targeting of non-small cell lung cancer using 111In-labeled HMFG1 F(ab')2 fragments.
    Kalofonos HP; Sivolapenko GB; Courtenay-Luck NS; Snook DE; Hooker GR; Winter R; McKenzie CG; Taylor-Papadimitriou JJ; Lavender PJ; Epenetos AA
    Cancer Res; 1988 Apr; 48(7):1977-84. PubMed ID: 2832056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody.
    Hnatowich DJ; Gionet M; Rusckowski M; Siebecker DA; Roche J; Shealy D; Mattis JA; Wilson J; McGann J; Hunter RE
    Cancer Res; 1987 Nov; 47(22):6111-7. PubMed ID: 3664510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.
    Le Doussal JM; Chetanneau A; Gruaz-Guyon A; Martin M; Gautherot E; Lehur PA; Chatal JF; Delaage M; Barbet J
    J Nucl Med; 1993 Oct; 34(10):1662-71. PubMed ID: 8410279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.
    Hnatowich DJ; Rusckowski M; Brill AB; Siebecker DA; Misra H; Mardirossian G; Bushe H; Rescigno A; Stevens S; Johnson DK
    Cancer Res; 1990 Nov; 50(22):7272-8. PubMed ID: 2224858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor targeting properties of indium-111 labeled genetically engineered Fab' and F(ab')2 constructs of chimeric tumor necrosis treatment (chTNT)-3 antibody.
    Khawli LA; Alauddin MM; Hu P; Epstein AL
    Cancer Biother Radiopharm; 2003 Dec; 18(6):931-40. PubMed ID: 14969605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of tumor targeting with the anticarcinoembryonic antigen murine monoclonal antibody fragment, MN-14 F(ab)2.
    Juweid M; Sharkey RM; Behr TM; Swayne LC; Dunn R; Ying Z; Siegel JA; Hansen HJ; Goldenberg DM
    Cancer; 1996 Jul; 78(1):157-68. PubMed ID: 8646712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.
    Le Doussal JM; Gruaz-Guyon A; Martin M; Gautherot E; Delaage M; Barbet J
    Cancer Res; 1990 Jun; 50(11):3445-52. PubMed ID: 2334941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional and systemic distribution of anti-tumor x anti-CD3 heteroaggregate antibodies and cultured human peripheral blood lymphocytes in a human colon cancer xenograft.
    Nelson H; Ramsey PS; Kerr LA; McKean DJ; Donohue JH
    J Immunol; 1990 Nov; 145(10):3507-15. PubMed ID: 1700013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
    Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
    Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodistribution of indium-111-labeled OC 125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas.
    Chatal JF; Saccavini JC; Gestin JF; Thédrez P; Curtet C; Kremer M; Guerreau D; Nolibé D; Fumoleau P; Guillard Y
    Cancer Res; 1989 Jun; 49(11):3087-94. PubMed ID: 2720667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution of iodine-125 and indium-111 labeled OV-TL 3 intact antibodies and F(ab')2 fragments in tumor-bearing athymic mice.
    Massuger LF; Boerman OC; Corstens FH; Verheijen RH; Claessens RA; Poels LG; van den Broek WJ; Kenemans P
    Anticancer Res; 1991; 11(6):2051-7. PubMed ID: 1776839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor location using F(ab')2 mu from a monoclonal IgM antibody: pharmacokinetics.
    Ballou B; Reiland J; Levine G; Knowles B; Hakala TR
    J Nucl Med; 1985 Mar; 26(3):283-92. PubMed ID: 2857779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of human osteogenic sarcoma xenografts in nude mice by a monoclonal antibody labeled with radioiodine and indium-111.
    Sakahara H; Endo K; Nakashima T; Koizumi M; Kunimatsu M; Kawamura Y; Ohta H; Nakamura T; Tanaka H; Kotoura Y
    J Nucl Med; 1987 Mar; 28(3):342-8. PubMed ID: 3469333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model.
    Tahtis K; Lee FT; Smyth FE; Power BE; Renner C; Brechbiel MW; Old LJ; Hudson PJ; Scott AM
    Clin Cancer Res; 2001 Apr; 7(4):1061-72. PubMed ID: 11309358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity and biodistribution of indium-111-labeled monoclonal antibody to a human high molecular weight-melanoma associated antigen.
    Fawwaz RA; Wang TS; Estabrook A; Rosen JM; Hardy MA; Alderson PO; Srivastava SC; Richards P; Ferrone S
    J Nucl Med; 1985 May; 26(5):488-92. PubMed ID: 3989605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic colorectal cancer: radioimmunoscintigraphy with a stabilized In-111-labeled F(ab')2 fragment of an anti-CEA monoclonal antibody.
    Lamki LM; Patt YZ; Rosenblum MG; Shanken LJ; Thompson LB; Schweighardt SA; Frincke JM; Murray JL
    Radiology; 1990 Jan; 174(1):147-51. PubMed ID: 2294542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of circulating antigen and radiolabel stability on the biodistribution of an indium labelled antibody.
    Davidson BR; Babich J; Young H; Waddington W; Clarke G; Short M; Boulos P; Styles J; Dean C
    Br J Cancer; 1991 Nov; 64(5):850-6. PubMed ID: 1931605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of conjugation on the biodistribution of 111In-labelled anti-PAP and anti-PSA monoclonal antibodies examined in nude mice with PC-82 human tumor xenografts.
    Perälä-Heape M; Vihko P; Pelkonen I; Laine A; Vihko R
    In Vivo; 1991; 5(2):159-65. PubMed ID: 1722716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of the monoclonal antibody B72.3 and its fragments labeled with either 125I or 111In.
    Brown BA; Comeau RD; Jones PL; Liberatore FA; Neacy WP; Sands H; Gallagher BM
    Cancer Res; 1987 Feb; 47(4):1149-54. PubMed ID: 3802096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.